JAMDA publishes study backing EarlySense use
A new case report published in JAMDA — the Journal of Post Acute and Long-Term Care Medicine supports the use of EarlySense patient monitoring to detect acute pulmonary embolism.
Early Identification of Acute Pulmonary Emboli Through the Use of Contact-Free Continuous Patient Monitoring includes findings from a case study at Hebrew Home of Riverdale by RiverSpring Health showing that skilled nursing facilities incorporating contact-free, continuous patient monitoring can potentially aid in the early identification of acute changes in patient deterioration and rapid life-threatening treatment interventions.
A clinical poster on the topic was also presented at AMDA – The Society for Post-Acute and Long-Term Care Medicine’s 2020 Annual Conference.
“SNFs are faced with providing care for residents with increasing clinical complexity as residents are being discharged from hospitals to post-acute care earlier, and with multiple active comorbidities,” said author Zachary Palace, M.D., medical director at the Hebrew Home. “In this case study, the Hebrew Home clinical team was able to use continuous monitoring data to be notified of an immediate change in patient condition and make informed and time critical clinical decisions about the patient’s care.”
EarlySense is being used to care for COVID-19 patients in facilities around the world and is installed in more than 40,000 patient beds in healthcare facilities around the world.
Last year, the company was selected as “Best MedTech Startup” award by MedTech Breakthrough.